AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
MAYLARD INCISION FOR RADICAL HYSTERECTOMY AND PELVIC AND PARAAORTIC LYMPH-NODE DISSECTION
Authors: ANGIOLI R KOECHLI OR SEVIN BU
Citation: R. Angioli et al., MAYLARD INCISION FOR RADICAL HYSTERECTOMY AND PELVIC AND PARAAORTIC LYMPH-NODE DISSECTION, International journal of gynecological cancer, 8(4), 1998, pp. 274-278
AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: ASBURY R BLESSING JA BULLER R MALFETANO JH WALKER J SEVIN BU
Citation: R. Asbury et al., AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(2), 1998, pp. 145-146
PROFOUND THROMBOCYTOPENIA IN PREVIOUSLY TREATED PATIENTS WITH RECURRENT OVARIAN-CARCINOMA RECEIVING TOPOTECAN
Authors: ABENDSTEIN B KLINGLER PJ SEVIN BU
Citation: B. Abendstein et al., PROFOUND THROMBOCYTOPENIA IN PREVIOUSLY TREATED PATIENTS WITH RECURRENT OVARIAN-CARCINOMA RECEIVING TOPOTECAN, Gynecologic oncology, 69(2), 1998, pp. 176-177
CONSERVATIVE TRENDS IN THE SURGICAL-MANAGEMENT OF VULVAR CANCER - A UNIVERSITY-OF-MIAMI PATIENT-CARE EVALUATION STUDY
Authors: RODRIGUEZ M SEVIN BU AVERETTE HE ANGIOLI R JANICEK M METHOD M PENALVER A
Citation: M. Rodriguez et al., CONSERVATIVE TRENDS IN THE SURGICAL-MANAGEMENT OF VULVAR CANCER - A UNIVERSITY-OF-MIAMI PATIENT-CARE EVALUATION STUDY, International journal of gynecological cancer, 7(2), 1997, pp. 151-157
USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS
Authors: ANGIOLI R JANICEK M SEVIN BU ESTAPE R AVERETTE HE KOECHLI OR UNTCH M PENALVER M
Citation: R. Angioli et al., USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS, International journal of oncology, 11(4), 1997, pp. 777-780
RADIATION ENHANCEMENT OF GEMCITABINE(R) IN 3 HUMAN CERVICAL-CANCER CELL-LINES
Authors: WALLWIENER D KUREK R ANGIOLI R JANICEK M PENALVER M BLATTER J EBLE E DIEL IJ BASTERT G SEVIN BU
Citation: D. Wallwiener et al., RADIATION ENHANCEMENT OF GEMCITABINE(R) IN 3 HUMAN CERVICAL-CANCER CELL-LINES, European journal of cancer, 33, 1997, pp. 923-923
MODULATION OF CISPLATIN CYTOTOXICITY BY INTERLEUKIN-1-ALPHA AND RESIDENT TUMOR MACROPHAGES
Authors: BRAUNSCHWEIGER PG BASRUR VS CAMERON D SHARPE L SANTOS O PERRAS JP SEVIN BU MARKOE AM
Citation: Pg. Braunschweiger et al., MODULATION OF CISPLATIN CYTOTOXICITY BY INTERLEUKIN-1-ALPHA AND RESIDENT TUMOR MACROPHAGES, Biotherapy, 10(2), 1997, pp. 129-137
P53 INTERFERENCE AND GROWTH-INHIBITION IN P53-MUTANT AND OVEREXPRESSING ENDOMETRIAL CANCER CELL-LINES
Authors: JANICEK MF ANGIOLI R UNAL AD SEVIN BU MADRIGAL M ESTAPE R AVERETTE HE
Citation: Mf. Janicek et al., P53 INTERFERENCE AND GROWTH-INHIBITION IN P53-MUTANT AND OVEREXPRESSING ENDOMETRIAL CANCER CELL-LINES, Gynecologic oncology, 66(1), 1997, pp. 94-102
RADIOSENSITIVITY PATTERNS OF 4 HUMAN OVARIAN-CANCER CELL-LINES IN-VITRO
Authors: PETRU E SEVIN BU GOTTLIEB C
Citation: E. Petru et al., RADIOSENSITIVITY PATTERNS OF 4 HUMAN OVARIAN-CANCER CELL-LINES IN-VITRO, Gynecologic oncology, 64(3), 1997, pp. 490-492
IN-VITRO ANTIGENE THERAPY TARGETING HPV-16 E6 AND E7 IN CERVICAL-CARCINOMA
Authors: MADRIGAL M JANICEK MF SEVIN BU PERRAS J ESTAPE R PENALVER M AVERETTE HE
Citation: M. Madrigal et al., IN-VITRO ANTIGENE THERAPY TARGETING HPV-16 E6 AND E7 IN CERVICAL-CARCINOMA, Gynecologic oncology, 64(1), 1997, pp. 18-25
TUMOR HETEROGENEITY AND IN-VITRO CHEMOSENSITIVITY TESTING IN OVARIAN-CANCER
Authors: SEVIN BU PERRAS JP
Citation: Bu. Sevin et Jp. Perras, TUMOR HETEROGENEITY AND IN-VITRO CHEMOSENSITIVITY TESTING IN OVARIAN-CANCER, American journal of obstetrics and gynecology, 176(4), 1997, pp. 759-766
USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER
Authors: ANGIOLI R SEVIN BU UNTCH M KOCHLI OR ESTAPE R AVERETTE HE
Citation: R. Angioli et al., USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER, Oncology Reports, 3(2), 1996, pp. 351-354
DANAZOL RELIEVES REFRACTORY PRURITUS ASSOCIATED WITH MYELOPROLIFERATIVE DISORDERS AND OTHER DISEASES
Authors: KOLODNY L HORSTMAN LL SEVIN BU BROWN H AHN YS
Citation: L. Kolodny et al., DANAZOL RELIEVES REFRACTORY PRURITUS ASSOCIATED WITH MYELOPROLIFERATIVE DISORDERS AND OTHER DISEASES, American journal of hematology, 51(2), 1996, pp. 112-116
MANAGEMENT OF STAGE I-B, II-A, AND II-B CARCINOMA OF THE CERVIX WITH HIGH-DOSE-RATE BRACHYTHERAPY - INITIAL RESULTS OF AN INSTITUTIONAL CLINICAL-TRIAL
Authors: ABITBOL AA WOLFSON AH LEWIN AA HOUDEK PV LAUFER KA BRANDON AH TING JY RAUB WA AVERETTE HE SEVIN BU MARKOE AM
Citation: Aa. Abitbol et al., MANAGEMENT OF STAGE I-B, II-A, AND II-B CARCINOMA OF THE CERVIX WITH HIGH-DOSE-RATE BRACHYTHERAPY - INITIAL RESULTS OF AN INSTITUTIONAL CLINICAL-TRIAL, American journal of clinical oncology, 19(3), 1996, pp. 223-228
LYMPH-NODE METASTASES AND PROGNOSIS IN PATIENTS WITH STAGE IA(2) CERVICAL-CANCER
Authors: BUCKLEY SL TRITZ DM VANLE L HIGGINS R SEVIN BU UELAND FR DEPRIEST PD GALLION HH BAILEY CL KRYSCIO RJ FOWLER W AVERETTE H VANNAGELL JR
Citation: Sl. Buckley et al., LYMPH-NODE METASTASES AND PROGNOSIS IN PATIENTS WITH STAGE IA(2) CERVICAL-CANCER, Gynecologic oncology, 63(1), 1996, pp. 4-9
ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL
Authors: CURTIN JP HOSKINS WJ VENKATRAMAN ES ALMADRONES L PODRATZ KC LONG H TENERIELLO M AVERETTE H SEVIN BU
Citation: Jp. Curtin et al., ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL, Gynecologic oncology, 61(1), 1996, pp. 3-10
SURGICALLY DEFINED PROGNOSTIC PARAMETERS IN PATIENTS WITH EARLY CERVICAL-CARCINOMA - A MULTIVARIATE SURVIVAL TREE ANALYSIS
Authors: SEVIN BU LU Y BLOCH DA NADJI M KOECHLI OR AVERETTE HE
Citation: Bu. Sevin et al., SURGICALLY DEFINED PROGNOSTIC PARAMETERS IN PATIENTS WITH EARLY CERVICAL-CARCINOMA - A MULTIVARIATE SURVIVAL TREE ANALYSIS, Cancer, 78(7), 1996, pp. 1438-1446
EFFICACY OF RADICAL HYSTERECTOMY AS TREATMENT FOR PATIENTS WITH SMALL-CELL CARCINOMA OF THE CERVIX
Authors: SEVIN BU METHOD MW NADJI M LU Y AVERETTE HA
Citation: Bu. Sevin et al., EFFICACY OF RADICAL HYSTERECTOMY AS TREATMENT FOR PATIENTS WITH SMALL-CELL CARCINOMA OF THE CERVIX, Cancer, 77(8), 1996, pp. 1489-1493
THE ROLE OF RADIOIMMUNOSCINTIGRAPHY AND COMPUTED-TOMOGRAPHY SCAN PRIOR TO REASSESSMENT LAPAROTOMY OF PATIENTS WITH OVARIAN-CARCINOMA - A PRELIMINARY-REPORT
Authors: METHOD MW SERAFINI AN AVERETTE HE RODRIGUEZ M PENALVER MA SEVIN BU
Citation: Mw. Method et al., THE ROLE OF RADIOIMMUNOSCINTIGRAPHY AND COMPUTED-TOMOGRAPHY SCAN PRIOR TO REASSESSMENT LAPAROTOMY OF PATIENTS WITH OVARIAN-CARCINOMA - A PRELIMINARY-REPORT, Cancer, 77(11), 1996, pp. 2286-2293
EFFECT OF INTERFERONS ON HORMONE-RECEPTOR LEVELS OF ENDOMETRIAL CANCER-CELLS
Authors: ANGIOLI R SEVIN BU UNTCH M KOECHLI OR RODRIGUEZ M PERRAS JP AVERETTE HE
Citation: R. Angioli et al., EFFECT OF INTERFERONS ON HORMONE-RECEPTOR LEVELS OF ENDOMETRIAL CANCER-CELLS, Oncology Reports, 2(2), 1995, pp. 285-288
IS THERE A CORRELATION BETWEEN CELL-CYCLE PERTURBATIONS AND CHEMOSENSITIVITY IN OVARIAN-CANCER CELLS EXPOSED TO CYTOTOXIC DRUGS IN-VITRO
Authors: PETRU E HAAS J SCHAIDER H SEVIN BU
Citation: E. Petru et al., IS THERE A CORRELATION BETWEEN CELL-CYCLE PERTURBATIONS AND CHEMOSENSITIVITY IN OVARIAN-CANCER CELLS EXPOSED TO CYTOTOXIC DRUGS IN-VITRO, Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 15-18
IN-VITRO CHEMOSENSITIVITY OF PACLITAXEL AND OTHER CHEMOTHERAPEUTIC-AGENTS IN MALIGNANT GESTATIONAL TROPHOBLASTIC NEOPLASMS
Authors: KOECHLI OR SCHAER GN SEVIN BU PERRAS JP SCHENK V RODRIGUEZ M UNTCH M STEREN A HALLER U
Citation: Or. Koechli et al., IN-VITRO CHEMOSENSITIVITY OF PACLITAXEL AND OTHER CHEMOTHERAPEUTIC-AGENTS IN MALIGNANT GESTATIONAL TROPHOBLASTIC NEOPLASMS, Anti-cancer drugs, 6(1), 1995, pp. 94-100
COMBINATION ANTI-GENE THERAPY TARGETING C-MYC AND P53 IN OVARIAN-CANCER CELL-LINES
Authors: JANICEK MF SEVIN BU NGUYEN HN AVERETTE HE
Citation: Mf. Janicek et al., COMBINATION ANTI-GENE THERAPY TARGETING C-MYC AND P53 IN OVARIAN-CANCER CELL-LINES, Gynecologic oncology, 59(1), 1995, pp. 87-92
A CORRELATION OF CELL-CYCLE PERTURBATIONS WITH CHEMOSENSITIVITY IN HUMAN OVARIAN-CANCER CELLS EXPOSED TO CYTOTOXIC DRUGS IN-VITRO
Authors: PETRU E SEVIN BU HAAS J RAMOS R PERRAS J
Citation: E. Petru et al., A CORRELATION OF CELL-CYCLE PERTURBATIONS WITH CHEMOSENSITIVITY IN HUMAN OVARIAN-CANCER CELLS EXPOSED TO CYTOTOXIC DRUGS IN-VITRO, Gynecologic oncology, 58(1), 1995, pp. 48-57
PACLITAXEL - A RADIATION SENSITIZER OF HUMAN CERVICAL-CANCER CELLS
Authors: RODRIGUEZ M SEVIN BU PERRAS J NGUYEN HN PHAM C STEREN AJ KOECHLI OR AVERETTE HE
Citation: M. Rodriguez et al., PACLITAXEL - A RADIATION SENSITIZER OF HUMAN CERVICAL-CANCER CELLS, Gynecologic oncology, 57(2), 1995, pp. 165-169
Risultati: 1-25 | 26-50 | 51-54